"For more than 35 years, the ophthalmologists and optometrists at Barnet Dulaney Perkins Eye Center have been providing state-of-the-art medical and surgical eye care in Arizona. More people have entrusted the care of their eyes to our ophthalmology practice than to any other in the state. Our doctors use only the most advanced technologies and techniques to treat patients at all stages of life. Whether you need an annual eye exam, or may be experiencing signs of cataracts, hearing loss, or wish for corrective vision surgery, you can expect compassionate and convenient care from the doctors of Barnet Dulaney Perkins Eye Center."

During the past decade, Barnet Dulaney Perkins Eye Center conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 5 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 5 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Barnet Dulaney Perkins Eye Center" #1 collaborator was "Barnet Dulaney Perkins Eye Center" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator, "Iowa Eye Center, Cedar Rapids IA" with 1 trials as a collaborator, "Retina Consultants Houston" with 1 trials as a collaborator and "The University of Texas Health Science Center, Houston" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Barnet Dulaney Perkins Eye Center" are "Diabetic Macular Edema" (5 trials), "Neovascular Age-related Macular Degeneration" (3 trials), "Diabetic Retinopathy" (2 trials), "Macular Degeneration" (2 trials) and "Neovascular Age-Related Macular Degeneration" (2 trials). Many other conditions were trialed in "Barnet Dulaney Perkins Eye Center" in a lesser frequency.

Most popular intervention types in "Barnet Dulaney Perkins Eye Center" are "Drug" (14 trials), "Procedure" (4 trials), "Other" (3 trials), "Device" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (6 trials), "Sham Procedure" (5 trials), "Aflibercept" (3 trials), "Intravitreal Ranibizumab 0.5 mg Injection" (2 trials) and "PDS Implant Pre-Filled with 100 mg/mL Ranibizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Barnet Dulaney Perkins Eye Center" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Barnet Dulaney Perkins Eye Center". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Barnet Dulaney Perkins Eye Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Barnet Dulaney Perkins Eye Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".